View Older Stories View More Recent Stories

Oct 7, 2021 11:41AM PAVmed Acquires EsophaCap Manufacturer CapNostics LLC
Oct 7, 2021 09:30AM PAVmed (PAVM) Acquires CapNostics
Oct 7, 2021 09:30AM PAVmed Acquires EsophaCap Manufacturer CapNostics LLC
Sep 30, 2021 10:34AM PAVmed to Host Digital Health Virtual Investor Event
Sep 21, 2021 09:30AM PAVmed Subsidiary Veris Health Joins Microsoft for Startups Global Program and Engages Loka as Software Development Partner
Sep 7, 2021 10:04AM PAVmed to Participate in September Investor and MedTech Conferences
Aug 12, 2021 04:14PM PAVmed Provides Business Update and Preliminary Second Quarter 2021 Financial Results
Aug 10, 2021 09:30AM PAVmed Subsidiary Lucid Diagnostics Launches First Lucid Test Centers
Aug 5, 2021 09:30AM PAVmed to Present at the 41st Annual Canaccord Genuity Growth Conference
Aug 3, 2021 09:32AM PAVmed (PAVM) Appoints Aster Angagaw to its Board
Aug 3, 2021 09:30AM Global Industry Executive Aster Angagaw Joins PAVmed Subsidiary Lucid Diagnostics’ Board of Directors
Aug 2, 2021 09:30AM PAVmed to Hold Business Update Conference Call on August 12, 2021
Aug 2, 2021 09:30AM CORRECTING and REPLACING PAVmed to Hold Business Update Conference Call on August 12, 2021
Jul 28, 2021 09:31AM PAVmed (PAVM) Appoints Stanley N. Lapidus as VP and Board Member
Jul 28, 2021 09:30AM Stanley Lapidus, Founder and Former Chairman & CEO of Exact Sciences, Joins PAVmed Subsidiary Lucid Diagnostics as Vice Chairman of its Board of Directors
Jul 22, 2021 09:30AM PAVmed Subsidiary Lucid Diagnostics Launches Strategic Partnership with Direct-to-Consumer Telemedicine Company UpScriptHealth
Jun 14, 2021 09:30AM Tim Baxter, Former CEO of Samsung Electronics North America and Global Technology Industry Leader, Joins PAVmed Board of Directors
Jun 10, 2021 09:30AM PAVmed Subsidiary Lucid Diagnostics Completes European CE Mark Certification of its EsoGuard Esophageal DNA Test
Jun 2, 2021 09:30AM PAVmed Launches Digital Health Company Veris Health Inc.
May 26, 2021 09:30AM PAVmed Subsidiary Lucid Diagnostics Receives CE Mark Certification for its EsoCheck® Esophageal Cell Collection Device
May 25, 2021 09:31AM PAVmed (PAVM) Receives European CE Mark Certification for its CarpX® Minimally Invasive Carpal Tunnel Device
May 25, 2021 09:30AM PAVmed Receives European CE Mark Certification for its CarpX® Minimally Invasive Carpal Tunnel Device
May 24, 2021 09:30AM Data Presented at Digestive Disease Week 2021 Support Clinical Utility of PAVmed Subsidiary Lucid Diagnostics’ EsoCheck and EsoGuard Technologies
May 17, 2021 04:00PM PAVmed Provides Business Update and First Quarter 2021 Financial Results
May 13, 2021 09:30AM PAVmed Subsidiary Lucid Diagnostics Announces Upcoming Presentation at Digestive Disease Week 2021
May 6, 2021 09:30AM PAVmed Subsidiary Lucid Diagnostics Expands Commercial Leadership Team
May 3, 2021 09:30AM PAVmed to Hold Business Update Conference Call on May 17, 2021
Apr 29, 2021 09:30AM Dr. Jacque Sokolov Joins PAVmed Subsidiary Lucid Diagnostics’ Board of Directors
Apr 27, 2021 09:30AM Global Industry Executive Debbie White Joins PAVmed Board of Directors
Apr 15, 2021 09:30AM PAVmed Chairman & CEO Lishan Aklog, M.D. named Top 50 Healthcare Technology CEO by Healthcare Technology Report
Apr 8, 2021 09:30AM PAVmed to Present at the 20th Annual Needham Healthcare Conference
Mar 10, 2021 09:30AM PAVmed to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
Mar 3, 2021 09:30AM PAVmed Retires Convertible Debt
Mar 1, 2021 09:30AM PAVmed Chairman and Chief Executive Officer Lishan Aklog, M.D., Elected to AdvaMed Board of Directors
Feb 22, 2021 08:19AM PAVmed (PAVM) majority-owned subsidiary Lucid Diagnostics to spin-off into separate public company
Feb 22, 2021 08:18AM PAVmed Provides Business Update and Preliminary Fourth Quarter 2020 Financial Results
Feb 18, 2021 09:30AM PAVmed Reschedules Business Update Conference Call on February 22, 2021 to 8:30 AM EST
Feb 16, 2021 09:30AM First U.S. Patient Undergoes Successful Minimally Invasive Carpal Tunnel Release Using PAVmed’s CarpX® Device
Feb 9, 2021 09:30AM PAVmed to Hold Business Update Conference Call on February 22, 2021
Jan 8, 2021 10:53AM PAVmed Closes $13.4 Million Common Stock Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Jan 6, 2021 09:30AM PAVmed (PAVM) Announces Registered Direct Offering of its Common Stock
Jan 6, 2021 09:29AM PAVmed Announces Registered Direct Offering of its Common Stock Priced At-the-Market under Nasdaq Rules
Dec 22, 2020 12:04PM PAVmed Closes Additional $8.1 Million Common Stock Registered Direct Offering
Dec 18, 2020 09:29AM PAVmed (PAVM) Prices Additional $8.1 Million Common Stock Registered Direct Offering
Dec 18, 2020 09:29AM PAVmed Announces Pricing of Additional $8.1 Million Common Stock Registered Direct Offering
Dec 11, 2020 09:29AM PAVmed (PAVM) Announces 5.6M Share Registered Direct Offering of its Common Stock Priced at $1.60/sh
Dec 11, 2020 09:29AM PAVmed Announces Registered Direct Offering of its Common Stock
Nov 17, 2020 04:00PM PAVmed Reports Third Quarter 2020 Financial Results and Provides Business Update
Nov 2, 2020 09:30AM PAVmed to Hold Business Update Conference Call on November 17, 2020
Sep 8, 2020 09:30AM PAVmed to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference on September 15, 2020
View More Recent Stories View Older Stories